ZH4-65941-81291
2 vaccinations
4 coded responses
25 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 594 / MT
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Registered in v-safe
-
2021-03-12
Dose 1 — Pfizer-BioNTech
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-26
-
2021-04-02
Dose 2 — Pfizer-BioNTech
- 2021-04-02
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-04-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2021-04-07
-
2021-04-08
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising, Injection site erythema, Injection site swelling — Feeling: GoodFree text: The area around the injection went from red and swelling to looking more like a bruise.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
- 2021-04-16
- 2021-04-24
- 2021-05-02
- 2021-05-07
-
2021-05-14
Survey response — day 42, dose 2MedDRA: Nasal congestion, Nasopharyngitis, Oropharyngeal pain — Feeling: Good · Be unable to workFree text: Had a cold this week. Sore throat and stuffy nose. No fever. Lasted about four days and over the counter cold medicine provided relief from the symptoms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-02
-
2021-10-01
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis, Sinus disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Had a sinus cold this last week.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-02
Survey response — 12 months, dose 2MedDRA: Cough, Exercise tolerance decreased, Respiratory tract infection viral — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Had a bad respiratory virus that came with a cough that lasted about 8-weeks. The cough was so bad it kept me out of the gym for 3-weeks.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-02
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Pfizer-BioNTech | |
| 2 | 2021-04-02 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-02 | Unsuccessful |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): The area around the injection went from red and swelling to looking more like a bruise.
Release 8 — day 42, dose 2
Symptoms: Had a cold this week. Sore throat and stuffy nose. No fever. Lasted about four days and over the counter cold medicine provided relief from the symptoms.
Release 9 — 6 months, dose 2
Symptoms: Had a sinus cold this last week.
Release 11 — 12 months, dose 2
Symptoms: Had a bad respiratory virus that came with a cough that lasted about 8-weeks. The cough was so bad it kept me out of the gym for 3-weeks.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Exercise tolerance decreased | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory tract infection viral | · | · | ✓ |
| SD | Sinus disorder | · | · | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release